Karyotypic evolution in patients with myelodysplastic syndromes

Area of Science:

• Hematology
• Clinical Cytogenetics

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• Cytogenetic abnormalities are common in MDS and play a role in prognosis.

Purpose of the Study:

• To determine the frequency of karyotypic evolution in MDS patients.
• To correlate chromosomal changes with clinical outcomes, including leukemia transformation and mortality.

Main Methods:

• Serial cytogenetic studies were conducted on 33 patients diagnosed with MDS.
• Karyotypes were analyzed at presentation and during follow-up to assess for chromosomal instability.

Main Results:

• Cytogenetic abnormalities were present in 45% of patients initially, rising to 57% during the disease course.
• Unstable karyotypes were observed in 42% of patients.
• Trisomy 8, monosomy 7, and del5q were the most frequent abnormalities.
• Karyotypic evolution preceded leukemia in 23% of patients.
• Patients with unstable karyotypes had a significantly higher mortality rate (33%) compared to those with stable karyotypes (5%).

Conclusions:

• Karyotypic evolution is a frequent event in myelodysplastic syndromes.
• Chromosomal instability is associated with a poorer clinical prognosis, including increased risk of transformation to acute myeloid leukemia and death.